MedPath

Effect of the prebiotic OCEAN ACTIVES® Fucoidan in promoting a healthy intestinal microbiome

Phase 1
Conditions
Healthy Volunteers
Registration Number
RPCEC00000443
Lead Sponsor
Hermanos Ameijeiras Clinical Surgical Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
90
Inclusion Criteria

1.Healthy Individuals 19-65 years of age without distinction of sex or skin color who give their consent
to participate in the study.
2. Not consuming probiotic formulations at the time of recruitment for the study
3. Not taking anti-inflammatory drugs

Exclusion Criteria

1. Individuals with allergies to fish and/or shellfish.
2. Individuals who suffer from the dysbiosis studied and who are ingesting some type of
probiotic formulation at the time of starting the study.
3. Individuals for whom seaweed is part of normal diet.
4. Individuals who do not consent to participate in the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fecal Microbiome Taxonomic Profile and Predicted Functional Potential of the Microbiome (It will use the bioinformatic program PICRUSt as follows: a. Inflammation Index, b. Alpha Diversity, c. Beta Diversity, d. Compositional Analysis, e. LEfSe (Linear discriminant analysis Effect Size), i. Taxonomic, ii. Functional). Measurement time: At baseline (day 0), 1 month and, 3 months<br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath